GitHub Hit With Cyberattack

Related Link: 

A popular U.S. coding website is enduring an onslaught of Internet traffic meant for China’s most popular search engine, in an episode that security experts say represents a likely attempt by China to shut down anticensorship tools.

GNC to Test Supplements More

Related Link: 

GNC Holdings agreed to expand testing procedures for herbal supplements beyond current FDA requirements, following a probe by New York.

Korea Aerospace Industries Preferred Bidder for New Fighter Jet

Related Link: 

South Korea has named Korea Aerospace Industries the preferred bidder of a multibillion-dollar deal to develop a new fighter jet.

Salus Changes Mind About New Bid for RadioShack

Related Link: 

Salus Capital Partners, the hedge fund trying to gain control of RadioShack, has changed its mind about increasing its offer for the battered retail operation.

GM Ignition-Switch Death Toll Rises to 77 People

Related Link: 

The number of eligible deaths linked to the General Motors Co. faulty ignition switch stood at 77 Monday as the number of claims under review continues to fall.

DuPont Board Approves Governance Changes

Related Link: 

DuPont Co. said its board approved changes to the planned corporate governance structure for the performance-chemicals business that it is spinning off.

Amaya Sells Cadillac Jack to AGS

Related Link: 

Amaya Inc. on Monday said it has agreed to sell Cadillac Jack Inc., a gaming-machine supplier, to an affiliate of Apollo Global Management LLC for about 476 million Canadian dollars ($378 million).

EU Approves Biomet-Zimmer Merger

Related Link: 

Zimmer Holdings secured approval in the EU for its $13 billion acquisition of fellow orthopedic-device maker Biomet after agreeing to sell three businesses in Europe to assuage antitrust concerns.

Amgen Granted FDA Priority Review for Expanded Use of Kyprolis

Related Link: 

Amgen Inc. said the U.S. Food and Drug Administration granted priority review status to its supplemental new drug application for Kyprolis to treat patients with relapsed multiple myeloma who have received at least one prior therapy.

Lawsuit Exposes Tensions in Thomson Media Family

Related Link: 

A lawsuit aimed at a member of Canada’s Thomson family alleges serious governance lapses involving the company through which the country’s richest family controls media giant Thomson Reuters.

Syndicate content